Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$781M |
| 2 |
Nike
NKE
|
+$773M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$536M |
| 4 |
Texas Instruments
TXN
|
+$493M |
| 5 |
AGN
Allergan plc
AGN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$1.07B |
| 2 |
Qualcomm
QCOM
|
+$673M |
| 3 |
TJX Companies
TJX
|
+$603M |
| 4 |
NVIDIA
NVDA
|
+$431M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.31% |
| 2 | Consumer Discretionary | 17.37% |
| 3 | Healthcare | 13.5% |
| 4 | Communication Services | 13.08% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Pebblebrook Hotel Trust
PEB
$2.19B
| $41.1M | 0.04% |
1,406,308
-51,116
| -4% | -$1.48M |
|
|
MJN
302
DELISTED
Mead Johnson Nutrition Company
MJN
| $41M | 0.04% |
460,084
-626,153
| -58% | -$51.5M |
|
|
VRNT
303
DELISTED
Verint Systems
VRNT
| $41M | 0.04% |
1,854,548
+21,705
| +1% | +$423K |
|
304
Marathon Petroleum
MPC
$91.2B
| $40.8M | 0.04% |
806,961
-44,541
| -5% | -$2.22M |
|
|
DBD
305
DELISTED
Diebold Nixdorf Incorporated
DBD
| $40.4M | 0.04% |
1,315,498
-217,031
| -14% | -$6.13M |
|
|
VWR
306
DELISTED
VWR Corporation
VWR
| $40.4M | 0.04% |
1,431,121
-58,775
| -4% | -$1.57M |
|
307
Altria Group
MO
$122B
| $40.2M | 0.04% |
563,426
-86,112
| -13% | -$6.23M |
|
308
Microchip Technology
MCHP
$42.3B
| $40.1M | 0.04% |
1,086,540
+1,079,574
| +15,498% | +$38.1M |
|
|
SYNH
309
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $39.8M | 0.04% |
867,677
-356,203
| -29% | -$17.7M |
|
|
GNMK
310
DELISTED
GenMark Diagnostics, Inc
GNMK
| $39.7M | 0.04% |
3,098,742
-123,974
| -4% | -$1.49M |
|
|
XENT
311
DELISTED
Intersect ENT, Inc
XENT
| $39.7M | 0.04% |
2,314,870
-129,094
| -5% | -$1.81M |
|
312
General Dynamics
GD
$105B
| $39.5M | 0.04% |
210,872
-9,734
| -4% | -$1.8M |
|
313
Cheniere Energy
CQP
$30.5B
| $39.3M | 0.04% |
1,215,027
+64,815
| +6% | +$2M |
|
|
ADSW
314
DELISTED
Advanced Disposal Services Inc
ADSW
| $38.9M | 0.04% |
1,721,815
-90,389
| -5% | -$2.02M |
|
315
West Pharmaceutical
WST
$23.3B
| $38.9M | 0.04% |
476,311
-3,825
| -0.8% | -$320K |
|
316
Acadia Healthcare
ACHC
$2.99B
| $38.6M | 0.04% |
885,116
+52,158
| +6% | +$2.12M |
|
317
Agnico Eagle Mines
AEM
$73B
| $38.1M | 0.04% |
896,657
-59,035
| -6% | -$2.65M |
|
|
FLIR
318
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $38M | 0.04% |
1,047,255
-85,714
| -8% | -$3.09M |
|
|
FTR
319
DELISTED
Frontier Communications Corp.
FTR
| $37.5M | 0.04% |
1,169,011
-1,599,879
| -58% | -$73.3M |
|
|
VISN
320
Vistance Networks Inc
VISN
$2.67B
| $37.1M | 0.04% |
889,636
+1,769
| +0.2% | +$68.1K |
|
321
Littelfuse
LFUS
$10.2B
| $37.1M | 0.04% |
231,871
+7,670
| +3% | +$1.22M |
|
|
RDUS
322
DELISTED
Radius Health, Inc.
RDUS
| $37M | 0.04% |
957,056
+71,018
| +8% | +$2.98M |
|
|
TSRO
323
DELISTED
TESARO, Inc.
TSRO
| $37M | 0.04% |
240,219
| – | – |
|
|
ALR
324
DELISTED
Alere Inc
ALR
| $36.8M | 0.04% |
925,472
-160,908
| -15% | -$6.28M |
|
325
Biogen
BIIB
$29.5B
| $36.6M | 0.04% |
133,913
-8,373
| -6% | -$2.37M |
|
Similar funds
Jennison Associates's Q1 2017 Portfolio in Review
As of Q1 2017, Jennison Associates held 861 positions worth $93.2B, up 4.1% from $89.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jennison Associates withdrew a net $4.47B in Q1 2017, closing 224 positions and reducing 376 holdings. Its most notable exit was Mobileye N.V., an estimated $165M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jennison Associates opened a new position in Snap worth $119M.
- Jennison Associates's largest Q1 2017 buy was Snap: 5,289,727 shares worth $119M.
- Jennison Associates added most to Broadcom in Q1 2017, an estimated $781M increase.
- Jennison Associates's biggest Q1 2017 reduction was Starbucks, cutting an estimated $1.07B.
- Jennison Associates fully exited Mobileye N.V. in Q1 2017, selling an estimated $165M.
- Jennison Associates's ten largest holdings make up 26% of its $93.2B portfolio in Q1 2017.
- Jennison Associates opened 55 new positions and closed 224 in Q1 2017.
- Jennison Associates's portfolio value rose 4.1% quarter-over-quarter to $93.2B.
Based on Jennison Associates's 13F filing for Q1 2017, filed 28 Apr 2017.